News (1097)

GSK : Director/Pdmr Shareholding - Form 6-K PU
GSK : Governance and Remuneration report 2023 PU
GSK announces Dr Jeannie Lee to join the Board as Non-Executive Director | GSK AQ
GSK announces Wendy Becker to join the Board as Non-Executive Director | GSK AQ
GSK : announces Wendy Becker to join the Board as Non-Executive Director - Form 6-K PU
GSK : announces Wendy Becker to join the Board as Non-Executive Director PU
GSK : Director/Pdmr Shareholding - Form 6-K PU
Hunt prioritises tackling inflation over tax cuts amid pressure from Tory MPs AN
GSK CFO buys shares worth GBP321,500 AN
Haitong International Securities : The Third Asia Summit on Global Health Opens Today Haitong International Acts as Strategic Partner for the Second Consecutive Year Accelerating Healthcare Innovation and Investment Opportunities PU
US subsidies make UK financial reform urgent, business warns RE
UK pension system needs 'big reform' to ensure higher returns - Hunt AN
GSK : Proxy Form 2023 PU
GSK : AGM Notice 2023 PU
GSK : Corporate governance report 2022 PU
RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K) AQ
Rubius Therapeutics, Inc. Announces Board Changes CI
Factbox-Activist investor Bluebell's offensive against European giants heats up RE
Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appointed as successor AQ
GSK plc - Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appointed as successor AQ
GlaxoSmithKline : GSK Board changes - Form 6-K PU
GlaxoSmithKline : GSK Board changes PU
Board and Committee changes AQ
GlaxoSmithKline : Board and Committee changes - Form 6-K PU
London Stock Exchange : UK capital market reform set to receive boost as Chancellor welcomes new Taskforce PU
GSK announces Dr Vishal Sikka to join the Board as Non-Executive Director AQ
GlaxoSmithKline : Corporate Governance PU
GSK Reportedly Seeks Out Investment from Sovereign Wealth Funds CI
GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company AQ
GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director - Form 6-K PU
GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director PU
GSK names Johns Hopkins scientist to board ahead of consumer unit spinoff RE
GlaxoSmithKline : GSK on track with consumer split as buyout report boosts shares RE
Elliott Investment Boss Again Questions GlaxoSmithKline on Value Creation CI
GlaxoSmithKline Provides Information to the Shareholders CI
Mesoblast : Management Team PU
Bluebell Capital Provides Information to the Shareholders CI
Activist investor Bluebell takes stake in GSK RE
GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K) PU
Mesoblast : Management Team PU
GlaxoSmithKline : GSK delivers strong Q2 sales of £8.1 billion, +6% AER, +15% CER Total EPS 27.9p -39% AER, -28% CER; Adjusted EPS 28.1p +46% AER +71% CER (Form 6-K) PU
GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K) PU
GlaxoSmithKline : GSK appoints consumer head as CEO of new spin-off RE
GlaxoSmithKline : Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company (Form 6-K) PU
GlaxoSmithKline : Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company PU
1234NextSee all

Companies (2)

WESTWING GROUP SE 181 M $
Logo Westwing Group SE

Westwing Group SE is a Germany-based company specializing in the home and living e-commerce sector. The Company offers a broad range of home products, which include home decor products, home accessories, textiles and rugs, and large and small furniture, s ...

SKYLARK HOLDINGS CO., LTD. 3 285 M $
Logo Skylark Holdings Co., Ltd.

Skylark Holdings Co Ltd, former Skylark Co Ltd is primarily engaged in the restaurant business and also engaged in the development of businesses such as food sales and support for group companies. In the restaurant business, in addition to developing fami ...


Insiders




Picture Jonathan Symonds
Jonathan Symonds

Founder of Oxford University Centre for Business Taxation, Jonathan Richard Symonds is a British businessperson who has been the head of 8 different companies and is Non-Executive Chairman at GlaxoSmithKline Plc and Chairman at Proteus Digital Health, Inc. Mr. Symonds is also on the board of Genomics England Ltd. (former Chairman), Rubius Therapeutics, Inc. and Harrow School and Head-Corporate Finance & Strategy at Mesoblast Ltd. He previously was Chairman at The 100 Group, Chairman-Supervisory Board at Innocoll Holdings Plc Chairman at Innocoll, Inc. and Chairman-Supervisory Board for Innocoll AG (both are subsidiaries of Innocoll Holdings Plc), Chief Financial Officer of AstraZeneca Plc and Director-Finance at Zeneca Group Plc (a subsidiary of AstraZeneca Plc), Chief Financial Officer at Novartis AG, Managing Director at The Goldman Sachs Group, Inc., Director at Accounting Standards Board, Chairman at HSBC Bank Plc and Partner at KPMG LLP (Canada). Jonathan Richard Symonds received an undergraduate degree from the University of Hertfordshire.


Picture Symonds
Symonds

Symonds currently works at Berkeley Junior School, as Member-Governors Board.



Picture Shelley L. Symonds
Shelley L. Symonds

Shelley L.
Symonds
is currently the Vice President-Marketing at Right90, Inc. She previously worked as the Senior Director-Worldwide Marketing at Oracle Corp., Principal at Retix, Inc., Vice President-Marketing at Comergent Technologies, Inc., Principal at The ASK Group, Inc., Principal at Ingress Corp.
Bhd., and Principal at Ashton-Tate Corp.
She holds an MBA from the University of Southern California and an undergraduate degree from the University of California, Los Angeles.


Picture Wayne A. Symonds
Wayne A. Symonds

Wayne A.
Symonds
currently works at Methuen Construction Co., Inc., as Executive Vice President from 2016.


Picture Curtis N. Symonds
Curtis N. Symonds

Mr. Symonds is President of the T.
Howard Foundation, a non-profit organization devoted to promoting women and people of color in the satellite and telecommunications industries.
He is also President & CEO of Symonds Synergy Group, a marketing consulting firm.
He served as the Executive Vice President of Affiliate Sales & Marketing for Black Entertainment Television from 1988 to 2001, and he also was Executive Vice President of BET on Jazz from 1996 to 2001, President of BET Action Pay Per View from 1992 to 2001, and President of BET International from 1992 to 2001.
Prior to joining BET, he spent five years at ESPN, Inc. Mr. Symonds spent 10 years on the board of directors of the National Association of Minorities in Communications, and in 1998 he received the National Cable Television Association Vanguard Award for marketing excellence.
In 1997, he was presented the Black United Fund's Walter Bremond Achieving Against the Odds Award.


No results for this search